Home/ Supplements/ Omega 3/ Omega-3 Fatty Acids

Omega-3 Fatty Acids

product on market Softgel Capsule Trader Joe's Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Fish body oil provides omega-3 fatty acids, which have strong evidence for supporting cardiovascular health. Vitamin E is included as an antioxidant to protect the oils from oxidation. Research indicates these components are generally safe for consumption when taken as directed.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega-3 Fatty Acids
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
90
Servings
Fat/Fatty Acid
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 {Calories}
Total Fat
1 Gram(s) (2% DV)
1 IU (3.3% DV)
Market median: 80.0mg (1390 products) 179 studies (A:3, B:90)
Fish Body Oil
1100 mg

Other Ingredients

Gelatin Glycerine purified Water natural Mixed Tocopherols
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

SUGGESTED USE: Take one softgel daily with food.

Warnings & Precautions

STORE IN A COOL, DRY PLACE, OUT OF REACH OF CHILDREN.

Formulation Notes

1100 mg Fish Oil 500 mg Total EPA & DHA

Additional Information

STORE IN A COOL, DRY PLACE, OUT OF REACH OF CHILDREN.

MOLECULARLY DISTILLED

g

Fish oil derived from anchovies & sardines.

Metadata

Product Details

DSLD Entry Date2013-11-25
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID26741
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.